Sutro Biopharma, INC Form 4 insider transactions

Jane Chung, COO of Sutro Biopharma, reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC filing.

Anne Elizabeth Borgman, Chief Medical Officer of Sutro Biopharma, reports the acquisition of stock options and restricted stock units (RSUs) on March 5, 2024.

CFO of Sutro Biopharma, Edward Albini, reports acquisition of stock options and vesting of restricted stock units (RSUs) in a recent SEC filing.

William Newell, CEO of Sutro Biopharma, reports the vesting and subsequent withholding of shares to cover tax obligations related to restricted stock units.

Linda Fitzpatrick, Chief People & Communications Officer at Sutro Biopharma, reports the vesting and withholding of shares to cover tax obligations related to restricted stock units.

Jane Chung, President and COO of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

CFO and Secretary of Sutro Biopharma, Edward Albini, reports the vesting and withholding of shares to cover tax obligations.

Venkatesh Srinivasan, Chief Technical Operations Officer of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares.

William Newell, CEO of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Linda Fitzpatrick, Chief People & Communications Officer at Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Jane Chung, President and COO of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

CFO Edward Albini reports the vesting of restricted stock units and subsequent tax withholding by Sutro Biopharma.

Chief Medical Officer Anne Elizabeth Borgman reports the vesting and subsequent tax withholding of shares related to restricted stock units.